Researchers were able to dissect the immune response leading to successful recovery from COVID-19, which might be the secret to finding an effective vaccine. Image: Doherty Institute
Melbourne researchers have mapped immune responses from one of Australia’s first novel coronavirus (COVID-19) patients, showing the body’s ability to fight the virus and recover from the infection.
Researchers at the Peter Doherty Institute for Infection and Immunity (Doherty Institute) – a joint venture between the University of Melbourne and the Royal Melbourne hospital – were able to test blood samples at four different time points in an otherwise healthy woman in her 40s, who presented with COVID-19 and had mild-to-moderate symptoms requiring hospital admission.
Published today in Nature Medicine is a detailed report of how the patient’s immune system responded to the virus. One of the authors on the paper, research fellow Dr Oanh Nguyen said this was the first time that broad immune responses to COVID-19 have been reported.
“We looked at the whole breadth of the immune response in this patient using the knowledge we have built over many years of looking at immune responses in patients hospitalised with influenza,” Dr Nguyen said.
“Three days after the patient was admitted, we saw large populations of several immune cells, which are often a tell-tale sign of recovery during seasonal influenza infection, so we predicted that the patient would recover in three days, which is what happened.”
The research team was able to do this research so rapidly thanks to SETREP-ID (Sentinel Travellers and Research Preparedness for Emerging Infectious Disease), led by Royal Melbourne Hospital Infectious Diseases Physician Dr Irani Thevarajan at the Doherty Institute.
SETREP-ID is a platform that enables a broad range of biological sampling to take place in returned travellers in the event of a new and unexpected infectious disease outbreak, which is exactly how COVID-19 started in Australia.
“When COVID-19 emerged, we already had ethics and protocols in place so we could rapidly start looking at the virus and immune system in great detail,” Dr Thevarajan said.
“Already established at a number of Melbourne hospitals, we now plan to roll out SETREP-ID as a national study.”
Working together with University of Melbourne Professor Katherine Kedzierska, a laboratory head at the Doherty Institute and a world-leading influenza immunology researcher, the team were able to dissect the immune response leading to successful recovery from COVID-19, which might be the secret to finding an effective vaccine.
“We showed that even though COVID-19 is caused by a new virus, in an otherwise healthy person, a robust immune response across different cell types was associated with clinical recovery, similar to what we see in influenza,” Professor Kedzierska said.
“This is an incredible step forward in understanding what drives recovery of COVID-19. People can use our methods to understand the immune responses in larger COVID-19 cohorts, and also understand what’s lacking in those who have fatal outcomes.”
Dr Thevarajan said that current estimates show more than 80 per cent of COVID-19 cases are mild-to-moderate, and understanding the immune response in these mild cases is very important research.
“We hope to now expand our work nationally and internationally to understand why some people die from COVID-19, and build further knowledge to assist in the rapid response of COVID-19 and future emerging viruses,” she said.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
- NFL: Team facilities to be closed in response to COVID-19 surgeon November 28, 2020 at 2:45 pm
The NFL decided to prohibit in-person team activities on Monday and Tuesday given rising COVID-19 cases around the country and because a number of players celebrated U.S. Thanksgiving with out-of-town ...
- Bay Area tightens COVID-19 restrictions; Santa Clara County orders travel quarantineon November 28, 2020 at 2:27 pm
At the same time, Santa Clara County issued its own tightened COVID-19 rules that in some ways are stricter than the ones issued by Los Angeles County on Friday. Under Santa Clara County‘s directive, ...
- India's Modi visits key vaccine facilities as COVID-19 cases surgeon November 28, 2020 at 2:25 pm
Indian Prime Minister Narendra Modi toured three of the nation's leading vaccine development and manufacturing sites on Saturday as coronavirus cases continue to soar.
- Ravens add 6, Steelers RB Conner goes on COVID-19 list, tooon November 28, 2020 at 2:19 pm
The Pittsburgh Steelers placed running back James Conner on the reserve/COVID-19 list on Saturday, while their scheduled opponent next Tuesday, the division rival Baltimore Ravens, added six ...
- US Coronavirus: The country is 'rounding the corner into a calamity,' expert says, with Covid-19 deaths projected to double soonon November 28, 2020 at 2:10 pm
As Thanksgiving week draws to an end, more experts are warning the Covid-19 pandemic will likely get much worse in the coming weeks before a possible vaccine begins to offer some relief.
Go deeper with Google Headlines on:
Go deeper with Bing News on:
Covid-19 immune system response
- These at-home exercises can help older people boost their immune system in the age of COVID-19on November 28, 2020 at 5:24 am
The good news is that regular exercise can significantly reduce the risk COVID-19 poses to older adults by improving overall health ...
- Natural ways to boost the immune system with Flu Season peaking amidst the COVID-19 pandemic.on November 24, 2020 at 3:53 pm
Dr. Anya Temer D.O. of Total Holistic Center in southern Florida, combines her experience as a family medicine practitioner, with current approaches to complete ...
- These at-home exercises can help older people boost their immune system and overall health in the age of COVID-19on November 24, 2020 at 7:32 am
Older adults, especially those over 65, have five times the risk of hospitalization and 90 times the risk of death from COVID-19 compared with younger adults.
- Oxford Covid-19 Vaccine Induces ‘Robust’ Immune Response In Older Adults, Early Findings Showon November 19, 2020 at 6:41 am
The Covid-19 vaccine being developed by the University of Oxford and AstraZeneca is safe and able to generate a “robust” immune response in older adults, according to early findings from Phase 2 ...
- Oxford's COVID-19 vaccine is safe and produces an immune response in older adults, encouraging early trial results suggeston November 19, 2020 at 3:12 am
Results of phase 3 trials — which will show whether the Oxford University vaccine can prevent COVID-19 — are expected before the end of the year.